COVID-19 Puts the World Health Organization ’s Emergency Use Listing (EUL) to Work
The World Health Organizationâs Emergency Use Listing (EUL) provides an approach for assessing medicines, vaccines, and diagnostics that could help address an outbreak classified by the WHO as a Public Health Emergency of International Concern (PHEIC). Robyn Meurant, executive director, regulatory services, IVDs and medical devices for NSF International, describes the EUL as âakin to the U.S. FDAâs Emergency Use Authorizationâ and says it could help countries that are âwithout great means to do testing.â Before joining NSF International, Meurant acted both as a professional officer and an advisor to WHO and assisted with the development of the EUL for IVDs in 2014.
MD+DI asked Meurant a few questions about the WHOâs EUL and how it could help IVD and device manufacturers respondâand healthcare systems manageâthe COVID-19 pandemic.
Â
What is the Emergency Use Listing (EUL) for WHO and how would it pertain to diagnostics manufacturers?
Meurant: The World Health Organizationâs Emergency Use Listing, or EUL, was developed in 2014 in response to the Ebola outbreak in three west African nations. Akin to the FDAâs Emergency Use Authorization (EUA), itâs an assessment for medicines, vaccines, and devices used to address an outbreak classified by the...
Source: MDDI - Category: Medical Devices Authors: Daphne Allen Tags: Regulatory and Compliance Source Type: news
More News: African Health | China Health | COVID-19 | Ebola | Ebola Vaccine | Emergency Medicine | Epidemiology | International Medicine & Public Health | Laboratory Medicine | Marketing | Medical Devices | Outbreaks | Pandemics | Vaccines | WHO